BRISTOL-MYERS SQUIBB CO (1BMY.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1BMY - US1101221083 - Common Stock
39.635 EUR
+1.23 (+3.22%)
Overall 1BMY gets a fundamental rating of 6 out of 10. We evaluated 1BMY against 55 industry peers in the Pharmaceuticals industry. 1BMY has an average financial health and profitability rating. 1BMY is valued quite cheap, while showing a decent growth score. This is a good combination! Finally 1BMY also has an excellent dividend rating. These ratings would make 1BMY suitable for value and dividend investing!
1. Profitability
1.1 Basic Checks
1BMY had positive earnings in the past year.
1BMY had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1BMY reported negative net income in multiple years.
1BMY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1BMY has a Return On Assets (6.23%) which is in line with its industry peers.
With a decent Return On Equity value of 32.55%, 1BMY is doing good in the industry, outperforming 80.00% of the companies in the same industry.
1BMY has a better Return On Invested Capital (17.49%) than 81.82% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1BMY is in line with the industry average of 13.65%.
The last Return On Invested Capital (17.49%) for 1BMY is above the 3 year average (11.67%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROIC | 17.49% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
1.3 Margins
1BMY's Profit Margin of 12.57% is in line compared to the rest of the industry. 1BMY outperforms 52.73% of its industry peers.
The Operating Margin of 1BMY (33.51%) is better than 81.82% of its industry peers.
In the last couple of years the Operating Margin of 1BMY has declined.
1BMY has a Gross Margin of 73.15%. This is comparable to the rest of the industry: 1BMY outperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of 1BMY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% |
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1BMY is creating value.
The number of shares outstanding for 1BMY has been reduced compared to 1 year ago.
1BMY has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1BMY has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.10 indicates that 1BMY is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.10, 1BMY is doing worse than 60.00% of the companies in the same industry.
The Debt to FCF ratio of 1BMY is 3.20, which is a good value as it means it would take 1BMY, 3.20 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.20, 1BMY is doing good in the industry, outperforming 61.82% of the companies in the same industry.
1BMY has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of 1BMY (2.41) is worse than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Altman-Z | 2.1 |
ROIC/WACC2.11
WACC8.3%
2.3 Liquidity
A Current Ratio of 1.27 indicates that 1BMY should not have too much problems paying its short term obligations.
The Current ratio of 1BMY (1.27) is worse than 65.45% of its industry peers.
A Quick Ratio of 1.17 indicates that 1BMY should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.17, 1BMY is doing good in the industry, outperforming 65.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
1BMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 460.68%, which is quite impressive.
The earnings per share for 1BMY have been decreasing by -24.57% on average. This is quite bad
Looking at the last year, 1BMY shows a small growth in Revenue. The Revenue has grown by 1.26% in the last year.
The Revenue has been growing by 13.06% on average over the past years. This is quite good.
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
3.2 Future
Based on estimates for the next years, 1BMY will show a very strong growth in Earnings Per Share. The EPS will grow by 35.26% on average per year.
1BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.97% yearly.
EPS Next Y479.55%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
EPS Next 5Y35.26%
Revenue Next Year0.19%
Revenue Next 2Y-4.06%
Revenue Next 3Y-3.05%
Revenue Next 5Y-4.97%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1BMY is valuated cheaply with a Price/Earnings ratio of 7.04.
Based on the Price/Earnings ratio, 1BMY is valued cheaper than 94.55% of the companies in the same industry.
1BMY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.19.
1BMY is valuated cheaply with a Price/Forward Earnings ratio of 7.57.
1BMY's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BMY is cheaper than 90.91% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.88. 1BMY is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.04 | ||
| Fwd PE | 7.57 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 92.73% of the companies listed in the same industry.
100.00% of the companies in the same industry are more expensive than 1BMY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.14 | ||
| EV/EBITDA | 5.97 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1BMY has a very decent profitability rating, which may justify a higher PE ratio.
1BMY's earnings are expected to grow with 73.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y131.22%
EPS Next 3Y73.98%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.77%, 1BMY is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.60, 1BMY pays a better dividend. On top of this 1BMY pays more dividend than 90.91% of the companies listed in the same industry.
1BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.77% |
5.2 History
On average, the dividend of 1BMY grows each year by 11.67%, which is quite nice.
Dividend Growth(5Y)11.67%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1BMY pays out 82.81% of its income as dividend. This is not a sustainable payout ratio.
1BMY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP82.81%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
BIT:1BMY (11/20/2025, 7:00:00 PM)
39.635
+1.23 (+3.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners81.74%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap80.69B
Revenue(TTM)48.03B
Net Income(TTM)6.04B
Analysts67.65
Price Target45.28 (14.24%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.77% |
Yearly Dividend2.07
Dividend Growth(5Y)11.67%
DP82.81%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)6.92%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)18.72%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.52%
EPS beat(12)11
Avg EPS beat(12)11.66%
EPS beat(16)15
Avg EPS beat(16)10.13%
Revenue beat(2)2
Avg Revenue beat(2)4.61%
Min Revenue beat(2)2.43%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)4.63%
Min Revenue beat(4)2.43%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.95%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.64%
PT rev (1m)2.04%
PT rev (3m)-2%
EPS NQ rev (1m)5.31%
EPS NQ rev (3m)4.49%
EPS NY rev (1m)0.33%
EPS NY rev (3m)0.41%
Revenue NQ rev (1m)1.98%
Revenue NQ rev (3m)2.19%
Revenue NY rev (1m)1.32%
Revenue NY rev (3m)1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.04 | ||
| Fwd PE | 7.57 | ||
| P/S | 1.96 | ||
| P/FCF | 6.14 | ||
| P/OCF | 5.65 | ||
| P/B | 5.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.97 |
EPS(TTM)5.63
EY14.2%
EPS(NY)5.23
Fwd EY13.2%
FCF(TTM)6.45
FCFY16.29%
OCF(TTM)7.01
OCFY17.69%
SpS20.26
BVpS7.83
TBVpS-9.98
PEG (NY)0.01
PEG (5Y)N/A
Graham Number31.49
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROCE | 23.41% | ||
| ROIC | 17.49% | ||
| ROICexc | 22.99% | ||
| ROICexgc | 117.18% | ||
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% | ||
| FCFM | 31.86% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
ROICexc(3y)13.73%
ROICexc(5y)11.71%
ROICexgc(3y)74.95%
ROICexgc(5y)76.74%
ROCE(3y)15.62%
ROCE(5y)13.15%
ROICexgc growth 3Y-16.88%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y7.41%
ROICexc growth 5Y19.82%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Debt/EBITDA | 2.13 | ||
| Cap/Depr | 26.84% | ||
| Cap/Sales | 2.75% | ||
| Interest Coverage | 7.66 | ||
| Cash Conversion | 79.11% | ||
| Profit Quality | 253.39% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.1 |
F-Score6
WACC8.3%
ROIC/WACC2.11
Cap/Depr(3y)12.09%
Cap/Depr(5y)10.53%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
EPS Next Y479.55%
EPS Next 2Y131.22%
EPS Next 3Y73.98%
EPS Next 5Y35.26%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
Revenue Next Year0.19%
Revenue Next 2Y-4.06%
Revenue Next 3Y-3.05%
Revenue Next 5Y-4.97%
EBIT growth 1Y44.7%
EBIT growth 3Y0.79%
EBIT growth 5Y8.21%
EBIT Next Year262.1%
EBIT Next 3Y50.55%
EBIT Next 5Y23.19%
FCF growth 1Y30.91%
FCF growth 3Y-2.91%
FCF growth 5Y14.03%
OCF growth 1Y28.71%
OCF growth 3Y-2.14%
OCF growth 5Y13.49%
BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ
Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a fundamental rating of 6 / 10 to 1BMY.MI.
Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a valuation rating of 9 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 5 / 10.
Can you provide the financial health for 1BMY stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.
Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?
The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 8 / 10 and the dividend payout ratio is 82.81%.